Related Experiment Video
Updated: Jul 16, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Neuroleptic malignant syndrome precipitated by chlorpromazine: a case report
Abdirahman Abdikadir Osman1, Hussein Mahdi Ahmed1, Mustafa Abdulrahman Ali2
1Internal Medicine Department, Royal Hospital, Mogadishu, Somalia.
Background:
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal reaction to dopamine-blocking agents. Although most commonly associated with prolonged or high-dose antipsychotic use, it can also occur after a single therapeutic dose.
Case Presentation:
A 56-year-old Somali man developed acute NMS within hours of receiving a single intramuscular dose of chlorpromazine for agitation, presenting with hyperthermia, severe rigidity, altered mental status, autonomic instability, and markedly elevated creatine kinase levels. Alternative diagnoses were excluded, and prompt discontinuation of chlorpromazine with supportive care and bromocriptine resulted in rapid clinical and biochemical recovery.
Conclusion:
This case highlights that NMS may occur rapidly following a single lowtherapeutic dose of chlorpromazine. Early recognition and timely management are essential for favorable outcomes. To our knowledge, this is the first reported case of chlorpromazine-induced NMS from Somalia.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

